Co-fhaclan:

Defactinib; VS 6063; VS6063; VS-6063; Defactinib (PF-04554878); N-methyl-4- (4- ((3- (N-methylmethan-3-ylsulfonamido) pyrazin-2-yl) methylamino)-5 - (trifluoromethyl) pyrimidin-2-ylamino) benzamide; N-methyl-4- ((4- ((3- (N-methylsulfonamido) pyrazin-2-yl) methyl) amino)-5- (trifluoromethyl) pyrimidin- 2-il) amino) benzamide Defactinib (PF-04554878)(VS-6063);N-Methyl-4-[[4-[[[3-[methyl(methylsulfonyl)amino]-2-pyrazinyl]methyl]amino] -5-(trifluoromethyl)-2-pyrimidinyl] amino] benzamide

Dùmhlachd:1.495 ± 0.06g / cm3 (Ro-shealladh)

PKA:15.16 ± 0.46 (Air a ro-innse)